| 125.61 -0.4 (-0.32%) | 04-07 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 155.68  |
1-year : | 165.06 |
| Resists | First : | 133.29 |
Second : | 141.32 |
| Pivot price | 124.88 |
|||
| Supports | First : | 120.3 | Second : | 100.09 |
| MAs | MA(5) : | 126.08  |
MA(20) : | 126.2 |
| MA(100) : | 126.66 |
MA(250) : | 136.13 |
|
| MACD | MACD : | -2.1 |
Signal : | -2.5 |
| %K %D | K(14,3) : | 50.7 |
D(3) : | 50.3 |
| RSI | RSI(14): 43.4 |
|||
| 52-week | High : | 163.04 | Low : | 102.83 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ATR ] has closed below upper band by 40.8%. Bollinger Bands are 38.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 127.35 - 127.99 | 127.99 - 128.52 |
| Low: | 123.31 - 123.99 | 123.99 - 124.55 |
| Close: | 124.61 - 125.68 | 125.68 - 126.56 |
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Thu, 02 Apr 2026
AptarGroup, Inc. (ATR) Stock forecasts - Yahoo Finance UK
Wed, 01 Apr 2026
How Investors May Respond To AptarGroup (ATR) Powering ENA’s Phase II Intranasal Antiviral Study - simplywall.st
Fri, 20 Mar 2026
AptarGroup (NYSE:ATR) Stock Rating Upgraded by Wells Fargo & Company - MarketBeat
Fri, 20 Mar 2026
AptarGroup (ATR) Receives Analyst Upgrade with Increased Price T - GuruFocus
Wed, 18 Mar 2026
AptarGroup Hires New CEO - Benzinga
Mon, 16 Mar 2026
Latest ATR News - Aptar to Present at 39th Annual J.P. Morgan ... - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 64 (M) |
| Shares Float | 64 (M) |
| Held by Insiders | 1.1 (%) |
| Held by Institutions | 95.6 (%) |
| Shares Short | 1,270 (K) |
| Shares Short P.Month | 1,180 (K) |
| EPS | 5.88 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 41.56 |
| Profit Margin | 10.3 % |
| Operating Margin | 11.2 % |
| Return on Assets (ttm) | 6.6 % |
| Return on Equity (ttm) | 15.1 % |
| Qtrly Rev. Growth | 13.5 % |
| Gross Profit (p.s.) | 21.95 |
| Sales Per Share | 59.27 |
| EBITDA (p.s.) | 12.6 |
| Qtrly Earnings Growth | -23.5 % |
| Operating Cash Flow | 570 (M) |
| Levered Free Cash Flow | 206 (M) |
| PE Ratio | 21.32 |
| PEG Ratio | 0 |
| Price to Book value | 3.02 |
| Price to Sales | 2.11 |
| Price to Cash Flow | 14.05 |
| Dividend | 0.47 |
| Forward Dividend | 0 |
| Dividend Yield | 0.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|